Basal insulin or longacting GLP-1 receptor agonists-making the right choice
- PMID: 24731676
- DOI: 10.1016/S2213-8587(14)70036-1
Basal insulin or longacting GLP-1 receptor agonists-making the right choice
Comment on
-
Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial.Lancet Diabetes Endocrinol. 2014 Jun;2(6):464-73. doi: 10.1016/S2213-8587(14)70029-4. Epub 2014 Apr 4. Lancet Diabetes Endocrinol. 2014. PMID: 24731672 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
